Boston Scientific Corporation (BSX)
5 Non-Tech Outperformers of 2024 Set to Fly Higher in the Near Term
Five non-technology high-flyers of 2024 have the potential to fly higher in the short term. These are: CMG, IBKR, KKR, FI, BSX.
Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now?
Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance.
Why Boston Scientific (BSX) is Poised to Beat Earnings Estimates Again
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Boston Scientific Corporation: Solid Financials And Upward Continuation
Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. The smooth upward movement of the stock indicates the quality of its investor base. Strong profit margins and robust growth expectations for the short-term future make me overlook its high valuation.
Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know
In the closing of the recent trading day, Boston Scientific (BSX) stood at $89.68, denoting a -1.08% change from the preceding trading day.
Why Boston Scientific (BSX) Outpaced the Stock Market Today
In the most recent trading session, Boston Scientific (BSX) closed at $91.07, indicating a +1.35% shift from the previous trading day.
4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow
Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport.
Boston Scientific (BSX) Rises Higher Than Market: Key Facts
Boston Scientific (BSX) reachead $89.86 at the closing of the latest trading day, reflecting a +1.02% change compared to its last close.
All You Need to Know About Boston Scientific (BSX) Rating Upgrade to Buy
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
FDA classifies recall of Boston Scientific catheters as 'most serious'
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's catheters used in a type of minimally invasive surgery as "most serious".
BSX Trades Near 52-Week High: Does the Stock Hold More Potential?
We believe Boston Scientific is one of those MedTech manufacturers that can be considered as the biggest gainers from the Fed's two successive interest rate cuts in 2024.
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
